A novel combinatorial approach using androgen receptor-targeted agents for treatment of prostate cancer

被引：0
|
作者：
Butler, Lisa [1 ]
Centenera, Margaret [1 ]
Marrocco, Deborah [1 ]
Carter, Sarah [1 ]
Bianco-Miotto, Tina [1 ]
Tilley, Wayne [1 ]
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2399
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer
    Matsubara, Nobuaki
    Yamada, Yoko
    Tabata, Ken-ichi
    Satoh, Takefumi
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Kawahara, Takashi
    Uemura, Hiroji
    Yano, Akihiro
    Kawakami, Satoru
    Otsuka, Masafumi
    Fukasawa, Satoshi
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E1073 - E1080
  • [12] Androgen Receptor-Targeted Therapy for Breast Cancer
    Lyons T.G.
    Traina T.A.
    Current Breast Cancer Reports, 2017, 9 (4) : 242 - 250
  • [13] Flutamide as an Alternative Anti-androgen Agent and Predictor of the Efficacy of Novel Androgen Receptor-targeted Agents
    Yamaguchi, Noriya
    Morizane, Shuichi
    Yumioka, Tetsuya
    Iwamoto, Hideto
    Hikita, Katsuya
    Sejima, Takehiro
    Honda, Masashi
    Takenaka, Atsushi
    ANTICANCER RESEARCH, 2019, 39 (07) : 3879 - 3885
  • [14] Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer
    Moll, Jan Matthijs
    Teubel, Wilma J.
    Erkens, Sigrun E.
    Jozefzoon-Agai, Ashraf
    Dits, Natasja F.
    van Rijswijk, Angelique
    Jenster, Guido W.
    van Weerden, Wytske M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [15] Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer A Review
    Kono, Miho
    Fujii, Takeo
    Lim, Bora
    Karuturi, Meghan Sri
    Tripathy, Debasish
    Ueno, Naoto T.
    JAMA ONCOLOGY, 2017, 3 (09) : 1266 - 1273
  • [16] Dynamic plasticity of prostate cancer intermediate cells during androgen receptor-targeted therapy
    Sandhu, Harkirat S.
    Portman, Kensey L.
    Zhou, Xianxiao
    Zhao, Julia
    Rialdi, Alexander
    Sfakianos, John P.
    Guccione, Ernesto
    Kyprianou, Natasha
    Zhang, Bin
    Mulholland, David J.
    CELL REPORTS, 2022, 40 (04):
  • [17] Summary statement:: Novel agents in the treatment of lung cancer:: Advances in epidermal growth factor receptor-targeted agents
    Lynch, Thomas J.
    Adjei, Alex A.
    Bunn, Paul A., Jr.
    Eisen, Tim G.
    Engelman, Jeffrey
    Goss, Glenwood D.
    Haber, Daniel A.
    Heymach, John V.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    Johnson, David H.
    Lilenbaum, Rogerio C.
    Meyerson, Matthew
    Sandler, Alan B.
    Sequist, Lecia V.
    Settleman, Jeffrey
    Wong, Kwok-Kin
    Hart, Carol S.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4365S - 4371S
  • [18] The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
    Li, Liuxun
    Xu, Jiangli
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (02): : 352 - 363
  • [19] The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
    Liuxun Li
    Jiangli Xu
    Clinical and Translational Oncology, 2023, 25 : 352 - 363
  • [20] Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer
    Pyrgidis, Nikolaos
    Vakalopoulos, Ioannis
    Sountoulides, Petros
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 20 (01): : 73 - 84
12345